Skip to main content

FDA

By Anthony Vecchione | 01:47 pm | June 27, 2025
Cirrus uses fMRI imaging to acquire and generate maps of critical brain networks to assist with brain surgery planning.  
By Anthony Vecchione | 12:24 pm | June 06, 2025
Elsa provides a secure platform for scientific reviewers and investigators to access internal documents.  
By Anthony Vecchione | 03:25 pm | May 28, 2025
The next-generation Swoop system software enhances image quality for ultra-low-field magnetic resonance imaging.   
By Anthony Vecchione | 04:02 pm | May 12, 2025
New NIH office will promote human-based research and scale the use of non-animal approaches to biomedical research.   
By Anthony Vecchione | 02:29 pm | April 25, 2025
Lilly accuses four compounders of selling unauthorized versions of the pharma giant's diabetes and weight-loss drugs.
By Anthony Vecchione | 04:34 pm | April 15, 2025
Data from the clinical trial might give patients a new option for treating migraines.
By Jessica Hagen | 12:02 pm | April 08, 2025
Ben Wolf, partner in Alston & Bird's Health Care Group, told MobiHealthNews how FDA staffing cuts could slow device approvals and what companies can do to stay ahead.
By Jessica Hagen | 01:07 pm | April 01, 2025
The judge ruled that the FDA overstepped its authority by regulating LDTs as medical devices, overturning the rule and remanding it to the HHS Secretary for review.
By Jessica Hagen | 12:22 pm | February 19, 2025
The firings included 20 individuals in the FDA's Office of Neurological and Physical Medicine Devices.
By Anthony Vecchione | 02:52 pm | January 07, 2025
The new draft guidance aims to help improve the accuracy of pulse oximeters in patients across the range of skin pigmentations.  

MobiHealthNews

September 18-19, 2025 | Chicago, IL

AI Leadership Strategy Summit

AI is transforming healthcare — but for executive leaders, adoption isn’t the only challenge. You need to make smart investments, implement proper governance, and deliver real results